Peer-reviewed veterinary case report
Best injection sites to fix soft palate air leaks in dogs
By Isomura, Emiko Tanaka et al.·Published in PloS one·2019·First Department of Oral and Maxillofacial Surgery, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Evaluation of sites of velopharyngeal structure augmentation in dogs for improvement of velopharyngeal insufficiency.
- Species:
- dog
Plain-English summary
A group of 10 young beagles, aged 20-24 months, was treated for a condition called velopharyngeal insufficiency (VPI), which causes nasal air leakage when they breathe. The dogs received saline injections at different sites in their mouths to see which location would best reduce this leakage. The injections into the nasal mucosa of the soft palate were the most successful, completely stopping the nasal air leakage after a specific volume of saline was used. This study suggests that targeting the soft palate may be the best approach for treating VPI in dogs.
People also search for: dog nasal air leakage treatment · beagle breathing problems · velopharyngeal insufficiency in dogs
Abstract
BACKGROUND: Velopharyngeal structure augmentation methods are used as alternatives to velopharyngeal plasty. Anatomic sites of implantation/injection vary widely due to a lack of standardized criteria. Here, we experimentally investigated optimal sites of velopharyngeal structure augmentation via saline injection in dogs as they naturally exhibit velopharyngeal insufficiency (VPI). METHODS: Velopharyngeal structure augmentation was performed on 10 beagles (age range: 20-24 months; weight range: 9-12 kg). Saline containing 1/80,000 epinephrine was injected intraorally in 1-mL increments into the nasal mucosa of the soft palate (n = 4), posterior pharyngeal wall (n = 3), or bilateral pharyngeal walls (n = 3) of each dog. Nasal air leakage was measured under rebreathing until velopharyngeal closure was achieved; the measurement was performed using flow meter sensors on both nasal apertures, and the oral cavity was filled with alginate impression material to prevent oral air leakage. RESULTS: Pre-injection, the dogs exhibited an average of 0.455 L/s air leakage from the nasal cavity. The dogs with saline injected into the nasal mucosa of the soft palate achieved steady augmentation, and nasal air leakage disappeared under rebreathing following 6-mL saline injection. Conversely, nasal air leakage remained in the dogs with saline injected in the posterior pharyngeal wall or bilateral pharyngeal walls. CONCLUSIONS: During VPI treatment in dogs, augmentation was most effective at the nasal mucosa of the soft palate. Improvement in nasal air leakage was highly dependent on the saline injection volume. Although velopharyngeal structures vary between dogs and humans, velopharyngeal closure style is similar. Thus, our results may aid in the treatment of VPI patients.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/30802272/